ArticleMolecular biology reports2019
Aberrant expression of long noncoding RNAs in the serum and myocardium of spontaneous hypertensive rats.
Article in Molecular biology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 5 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
Abstract
Circulating long noncoding RNAs as biomarkers of diseases have attracted increasing attention recently. However, circulating lncRNAs in hypertension is still unexplored niche. The levels of lncRNAs GAS5, NR024118, MRAK134679, AX765700 and MRNR026574 were measured in the serum and myocardium of hypertensive rats and normal controls with real time PCR. The levels of GAS5 were significantly higher both in the myocardium (P = 0.0067) and serum (P < 0.0001) of hypertensive rats compared with controls. The levels of NR024118 were remarkably higher in the myocardium of hypertensive rats (P = 0.0202) while the levels of serum NR024118 were not statistically significant in two groups (P = 0.6926). The levels of serum AX765700 (P = 0.0644) and cardiac AX765700 (P = 0.1938) were not statistically significant in hypertensive rats and controls. The levels of MRAK134679 were not different in the myocardium of two groups (P = 0.1692) and were too low in the serum to be detected. The levels of MRNR026574 were significantly higher in the myocardium of hypertensive rats compared with controls (P < 0.0001) and were too low in the serum to be detected. In conclusions, the levels of GAS5, NR024118 and MRNR026574 were increased in the myocardium of hypertensive rats, suggesting that they participate in the pathogenesis of hypertensive cardiac remodeling. Although, the levels of GAS5 in the serum and heart tissue were both significantly increased in SH rats, the potential biomarker capacity of GAS5 for HT needs to be further explored on larger human cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.